Theon International PLC
27.1.2026 18:01:54 CET | Globenewswire | Press release
IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH KEPLER CHEUVREUX
IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH KEPLER CHEUVREUX
PRESS RELEASE
Bloomberg (THEON:NA) / Reuters (THEON.AS)
27 January 2026 – Theon International Plc (THEON) appointed Kepler Cheuvreux as its liquidity agent in connection with THEON shares traded on Euronext Amsterdam. Pursuant to a liquidity agreement dated 21 January 2026 ("Liquidity Agreement"), the liquidity account in connection with this program comprises €1 million in cash and 33,000 shares.
The Liquidity Agreement will be implemented from 26 January 2026 for an initial period of one year and shall be renewed automatically thereafter for successive terms of twelve (12) months.
The execution of the Liquidity Agreement may be terminated: at any time and without notice by THEON; at any time by Kepler Cheuvreux with 60 days’ notice; or subject to customary conditions.
For inquiries, please contact:
| Investor Relations Nikos Malesiotis E-Mail: ir@theon.com Tel: +30 210 6772290 | Media Contact Elli Michou E-Mail: press@theon.com Tel: +30 210 6728610 |
About THEON GROUP
THEON GROUP of companies develops and manufactures cutting-edge night vision and thermal imaging systems for Defense and Security applications with a global footprint. THEON GROUP started its operations in 1997 from Greece and today occupies a leading role in the sector thanks to its international presence through subsidiaries and production facilities in Greece, Cyprus, Germany, the Baltics, the United States, the Gulf States, Switzerland, Denmark, Belgium, Singapore and South Korea. THEON GROUP has more than 250,000 systems in service with Armed and Special Forces in 72 countries around the world, 26 of which are NATO countries. ΤΗΕΟΝ ΙΝΤΕRNATIONAL PLC has been listed on Euronext Amsterdam (AMS: THEON) since February 2024.
www.theon.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
Zealand Pharma24.8.2026 17:05:00 CEST | Press release
Zealand Pharma – Notification of holding of treasury shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom